Imagene Announces a Collaboration with Tempus to Advance AI-Driven Diagnostics for Non-Small Cell Lung Cancer
Imagene Advances LungOI Commercialization With New Payment Code and Pricing, Complementing Its Prior CLIA Certified US Lab
Imagene Increases Accessibility of Rapid AI-Based Biomarker Profiling Through Integration With Sectra
Imagene Announces LungOI, the First AI-Based NSCLC Molecular Panel for Immediate Cancer Biomarker Profiling
Imagene Launches ImageneOI Platform on Oracle Cloud Infrastructure to Democratize AI-Based Molecular Profiling in Oncology
Imagene’s AI-Based Molecular Profiling Revolutionizes Lung Cancer Diagnostics: Two Patients Receive Immediate Targeted Therapy, Avert Brain Radiation
Imagene Welcomes World-Leading Oncologists at the Forefront of Precision Oncology to Its Scientific Advisory Board
Imagene Wins Frost & Sullivan’s Technology Innovation Leadership Award for Its Revolutionary AI-Based Molecular Testing for Cancer Diagnosis